Rick,
If guesses are acceptable, my guess is 1998. '98 appears in one of the links in your post.
www.training.nih.gov/jobfair/'98%20Participants/dgi.htm
Further, the document in the link states...
DGI presently has 19 employees and discovery programs in anti-cancer, immunoregulators, neuroprotectives, and growth enhancers.
Whereas their web site currently states
DGI BioTechnologies, Inc. is a biotechnology-based research company formed in January 1996 to develop its proprietary small molecule drug discovery platform, called Diogenesis®. DGI is majority owned, and fully funded by New Brunswick Scientific Co., Inc. (NBSC). DGI utilizes 10,000 sq. ft. of newly equipped laboratory space at NBSC's main facility in Edison, New Jersey. DGI presently has 30 employees in the fields of molecular immunology, molecular pharmacology, and structural biology. DGI will focus on the identification of novel site-directed assays and promising drug leads which regulate protein-protein interactions for license to pharmaceutical and biotechnology companies.
Looks like their employee population has grown by 50% since that post.
Currently advertised employment opportunities...
Employment Positions
DGI BioTechnologies, Inc. is a New Jersey company focused on the establishment of promising new drug assay platforms and discovering novel small molecule leads for license to pharmaceutical and biotechnology companies. Active research programs involve the design and construction of novel genes and proteins and obtaining structure-function data on drug targets and drug leads. We seek candidates for the following positions:
Protein Technologies Group - Posting May 15, 2000
Scientists
(Ph.D./MS/BS)
We have an immediate opportunity for a Research Scientist to join our Protein Technologies group to study protein:protein interactions. The successful candidate will be expected to perform expression, purification, and analysis of recombinant proteins and synthetic peptides. The position also requires experience in Biacore molecular interaction analysis and/or development of in vitro phosphorylation assays. Experienced candidates at levels from BS through post-doc will be considered for this opportunity. The position requires strong verbal communication skills, as well as willingness to take initiative and contribute in a team environment. Send to attention of Michael Lennick.
Molecular Biology
Scientists
(Ph.D./MS/BS)
Individuals with demonstrated abilities in molecular biology desired. Expertise in phage display or protein expression technologies or experience in receptor-ligand interactions required.
High-Throughput Screening
Individuals responsible for developing and performing receptor binding assays and operation of automated equipment for high throughput screening. Experience with computers and relational databases a plus.
Interested applicants are invited to send resume including salary requirements and references to:
DGI Biotechnologies, Inc.
P.O. Box 424
40 Talmadge Road
Edison, NJ 08818-0424
Perhaps this might provide some hints.
Stuart |
